We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+7.67%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$441M
AUM Growth
+$91.2M
(+26%)
Cap. Flow
+$74.5M
Cap. Flow
% of AUM
16.9%
Top 10 Holdings %
Top 10 Hldgs %
24.04%
Holding
1,099
New
222
Increased
266
Reduced
262
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$15.4M |
| 2 |
Stellantis
STLA
|
+$9.9M |
| 3 |
Alcon
ALC
|
+$7.77M |
| 4 |
Amazon
AMZN
|
+$6.64M |
| 5 |
Ferrari
RACE
|
+$5.26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Taiwan ETF
EWT
|
+$8.02M |
| 2 |
RSX
VanEck Russia ETF
RSX
|
+$6.88M |
| 3 |
Linde
LIN
|
+$5.74M |
| 4 |
iShares MSCI Saudi Arabia ETF
KSA
|
+$5.13M |
| 5 |
iShares MSCI Turkey ETF
TUR
|
+$4.56M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.26% |
| 2 | Technology | 13.6% |
| 3 | Financials | 12.86% |
| 4 | Healthcare | 10.91% |
| 5 | Industrials | 10.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
US Global Jets ETF
JETS
$746M
| $282K | 0.06% |
12,142
+5,392
| +80% | +$141K |
|
302
Axsome Therapeutics
AXSM
$12.4B
| $282K | 0.06% |
4,447
| – | – |
|
|
RCS
303
PIMCO Strategic Income Fund
RCS
$243M
| $281K | 0.06% |
37,047
+11,213
| +43% | +$85.1K |
|
|
SGEN
304
DELISTED
Seagen Inc. Common Stock
SGEN
| $281K | 0.06% |
1,952
-339
| -15% | -$50.4K |
|
305
West Fraser Timber
WFG
$5.18B
| $280K | 0.06% |
3,800
+3,100
| +443% | +$238K |
|
306
Sony
SONY
$123B
| $279K | 0.06% |
13,390
+9,000
| +205% | +$182K |
|
307
Yeti Holdings
YETI
$3.82B
| $278K | 0.06% |
3,009
-1,655
| -35% | -$144K |
|
308
Ambarella
AMBA
$2.99B
| $278K | 0.06% |
2,775
+174
| +7% | +$17.2K |
|
|
SWCH
309
DELISTED
Switch, Inc. Class A Common Stock
SWCH
| $275K | 0.06% |
13,205
-1,763
| -12% | -$33.8K |
|
310
Fortinet
FTNT
$112B
| $274K | 0.06% |
5,335
-120
| -2% | -$5.12K |
|
311
Spotify
SPOT
$99.2B
| $274K | 0.06% |
1,039
+48
| +5% | +$12.2K |
|
312
State Street SPDR S&P Retail ETF
XRT
$435M
| $274K | 0.06% |
+2,840
| New | +$265K |
|
313
Dycom Industries
DY
$12.9B
| $272K | 0.06% |
3,856
+3,012
| +357% | +$259K |
|
|
314
PUT
Linde
LIN
$237B
| $272K | 0.06% |
531
+182
| +52% | +$53.1K |
|
315
iShares Russell 1000 Value ETF
IWD
$82B
| $272K | 0.06% |
1,707
+112
| +7% | +$17.7K |
|
316
NovoCure
NVCR
$2.04B
| $271K | 0.06% |
1,438
-452
| -24% | -$87.9K |
|
317
Air Products & Chemicals
APD
$66.3B
| $271K | 0.06% |
+937
| New | +$275K |
|
318
Regeneron Pharmaceuticals
REGN
$68.8B
| $270K | 0.06% |
468
+93
| +25% | +$47.1K |
|
319
American Homes 4 Rent
AMH
$12B
| $269K | 0.06% |
6,553
-3,188
| -33% | -$118K |
|
320
Darling Ingredients
DAR
$9.93B
| $268K | 0.06% |
4,038
+242
| +6% | +$17K |
|
321
Johnson Outdoors
JOUT
$482M
| $266K | 0.06% |
2,301
-748
| -25% | -$100K |
|
322
Tenaris
TS
$29.1B
| $265K | 0.06% |
12,656
| – | – |
|
323
Chegg
CHGG
$108M
| $264K | 0.06% |
3,119
+140
| +5% | +$11.6K |
|
324
Medifast
MED
$108M
| $263K | 0.06% |
951
-291
| -23% | -$78.9K |
|
325
Cadence Design Systems
CDNS
$90B
| $262K | 0.06% |
+1,904
| New | +$252K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q2 2021 Portfolio in Review
As of Q2 2021, Exane Derivatives held 1,099 positions worth $441M, up 26% from $350M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Exane Derivatives deployed $74.5M of net new capital in Q2 2021, opening 222 new positions and adding to 266 existing holdings. Its largest new stake was Alcon: 109,041 shares worth $7.62M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 11% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares MSCI Taiwan ETF, an estimated $8.02M trimmed.
- Exane Derivatives's largest Q2 2021 buy was Alcon: 109,041 shares worth $7.62M.
- Exane Derivatives added most to UBS Group in Q2 2021, an estimated $15.4M increase.
- Exane Derivatives's biggest Q2 2021 reduction was iShares MSCI Taiwan ETF, cutting an estimated $8.02M.
- Exane Derivatives fully exited Deutsche Bank in Q2 2021, selling an estimated $4.27M.
- Exane Derivatives's ten largest holdings make up 24% of its $441M portfolio in Q2 2021.
- Exane Derivatives opened 222 new positions and closed 55 in Q2 2021.
- Exane Derivatives's portfolio value rose 26% quarter-over-quarter to $441M.
Based on Exane Derivatives's 13F filing for Q2 2021, filed 28 Jul 2021.